Dyspepsia Pipeline and Clinical Trials Pipeline Analysis 2023 5 Companies are working to impr - Benzinga
PCSA Stock | USD 0.60 0.01 1.64% |
About 62% of Processa Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Processa Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Processa Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Processa Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Processa |
Dyspepsia Pipeline and Clinical Trials Pipeline Analysis 2023 5 Companies are working to impr Benzinga
Read at news.google.com
![]() |
Processa Pharmaceuticals Fundamental Analysis
We analyze Processa Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Processa Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Processa Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Processa Pharmaceuticals is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Processa Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Processa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Processa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Processa Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Processa Pharmaceuticals Related Equities
SABS | SAB Biotherapeutics | 13.14 | ||||
IKT | Inhibikase Therapeutics | 5.38 | ||||
THRD | Third Harmonic | 4.96 | ||||
ANTX | AN2 Therapeutics | 4.67 | ||||
CELC | Celcuity LLC | 2.06 | ||||
INBX | Inhibrx | 1.90 | ||||
ACOGF | Alpha Cognition | 0.94 | ||||
ELVN | Enliven Therapeutics | 0.84 | ||||
FENC | Fennec Pharmaceuticals | 0.89 | ||||
AKTX | Akari Therapeutics | 0.92 | ||||
ARMP | Armata Pharmaceuticals | 2.01 | ||||
PMVP | Pmv Pharmaceuticals | 2.11 | ||||
ACXP | Acurx Pharmaceuticals | 2.63 | ||||
ANEB | Anebulo Pharmaceuticals | 7.64 |
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |